Trials / Sponsors / Katmai Pharmaceuticals Inc.
Katmai Pharmaceuticals Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1) Glioblastoma Multiforme | Phase 1 | 2022-02-25 |